IGF1 and Alzheimer disease: A specific IGF-1 polymorphism (rs972936 GG) was not only associated with increased serum IGF-1 levels, but was also more common in AD patients [47, 62], whereas another IGF-1 mutation (rs35767) increased serum IGF-1 [63] without association with AD.